blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1747230

EP1747230 - AMINOSULPHONYL-OR AMINOSULPHONYLAMINO-SUBSTITUTED PHENYL ESTERS AS ESTRADIOL PRODRUGS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.12.2010
Database last updated on 02.11.2024
Most recent event   Tooltip10.12.2010Application deemed to be withdrawnpublished on 12.01.2011  [2011/02]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
[2007/19]
Former [2007/15]For all designated states
Bayer Schering Pharma AG
Müllerstrasse 178
13353 Berlin / DE
Former [2007/05]For all designated states
Schering Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
Inventor(s)01 / WYRWA, Ralf
Burgstr. 47
07751 Oelknitz / DE
02 / DROESCHER, Peter
Lessingstr. 7
99425 Weimar / DE
03 / RING, Sven
Ziegenhainer Oberweg 3
07749 Jena / DE
04 / ELGER, Walter
Schorlemerallee 12b
14195 Berlin / DE
05 / SCHNEIDER, Birgitt
Damaschkeweg 19
07745 Jena / DE
06 / HILLISCH, Alexander
Zum Teller Hof 44
42553 Velbert / DE
07 / REDDERSEN, Gudrun
Friedrich-Engels-Str. 10
07749 Jena / DE
 [2007/05]
Application number, filing date05747458.710.05.2005
[2007/05]
WO2005EP05254
Priority number, dateDE2004102596621.05.2004         Original published format: DE102004025966
[2007/05]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2005113574
Date:01.12.2005
Language:DE
[2005/48]
Type: A1 Application with search report 
No.:EP1747230
Date:31.01.2007
Language:DE
The application published by WIPO in one of the EPO official languages on 01.12.2005 takes the place of the publication of the European patent application.
[2007/05]
Search report(s)International search report - published on:EP01.12.2005
ClassificationIPC:C07J41/00, A61K31/565, A61P5/30
[2007/05]
CPC:
C07J41/0072 (EP); A61P15/00 (EP); A61P15/10 (EP);
A61P15/18 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P5/24 (EP); A61P5/30 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/05]
Extension statesAL04.11.2006
BA04.11.2006
HR04.11.2006
LV04.11.2006
MK04.11.2006
YU04.11.2006
TitleGerman:AMINOSULFONYL- ODER AMINOSULFONYLAMINO-SUBSTITUIERTE PHENYL-ESTER ALS ESTRADIOL-PRODRUGS[2007/05]
English:AMINOSULPHONYL-OR AMINOSULPHONYLAMINO-SUBSTITUTED PHENYL ESTERS AS ESTRADIOL PRODRUGS[2007/05]
French:PHENYLESTERS SUBSTITUES PAR AMINOSULFONYLE OU AMINOSULFONYLAMINO COMME PROMEDICAMENTS A BASE D'OESTRADIOL[2007/05]
Entry into regional phase04.11.2006National basic fee paid 
04.11.2006Designation fee(s) paid 
04.11.2006Examination fee paid 
Examination procedure04.11.2006Examination requested  [2007/05]
07.02.2007Amendment by applicant (claims and/or description)
01.03.2010Communication of intention to grant the patent
13.07.2010Application deemed to be withdrawn, date of legal effect  [2011/02]
24.08.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2011/02]
Fees paidRenewal fee
16.04.2007Renewal fee patent year 03
17.04.2008Renewal fee patent year 04
25.05.2009Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.201006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]  - WILLIAMS J ET AL, "The oral administration of polysorbate 80 to the immature female rat does not increase uterine weight.", TOXICOLOGY LETTERS. 14 MAR 1997, (19970314), vol. 91, no. 1, ISSN 0378-4274, pages 19 - 24, XP002345468 [A] 1-17 * page 21, column 2, paragraphs 2-4 *

DOI:   http://dx.doi.org/10.1016/S0378-4274(96)03863-5
 [A]  - PUROHIT A ET AL, "Steroid sulphatase inhibitors for breast cancer therapy.", THE JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. SEP 2003, (200309), vol. 86, no. 3-5, ISSN 0960-0760, pages 423 - 432, XP002345469 [A] 1-17 * page 426, column 2, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/S0960-0760(03)00353-4
 [A]  - ELGER W ET AL, "ESTROGEN SULFAMATES: A NEW APPROACH TO ORAL ESTROGEN THERAPY", REPRODUCTION, FERTILITY AND DEVELOPMENT, CSIRO, EAST MELBOURNE, AU, (2001), vol. 13, no. 4, ISSN 1031-3613, pages 297 - 305, XP001113159 [A] 1-17 * page 302, column 1, paragraphs 2,3 * * page 303, column 2, paragraphs 1-3 *

DOI:   http://dx.doi.org/10.1071/RD01029
 [PA]  - CHANDER SURINDER K ET AL, "The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 10 SEP 2004, (20040910), vol. 322, no. 1, ISSN 0006-291X, pages 217 - 222, XP002345470 [PA] 1-17 * abstract *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2004.07.108
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.